The TRND program mission is to encourage and speed the development of new treatments for rare diseases with high unmet medical needs. By collaborating with TRND, investigators gain access to the world-class pre-clinical and early clinical development expertise of the National Center for Advancing Translational Sciences (NCATS, NIH).
TRND de-risks promising therapeutic candidates by generating robust IND-enabling data. In addition, TRND can also support certain clinical activities, including proof-of-concept trials and natural history studies. For more information, visit TRND on the web https://ncats.nih.gov/trnd